<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02949765</url>
  </required_header>
  <id_info>
    <org_study_id>Atto 302/2016</org_study_id>
    <nct_id>NCT02949765</nct_id>
  </id_info>
  <brief_title>Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease</brief_title>
  <official_title>Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anemia and sideropenia are a common effect of untreated celiac disease. In a portion of
      patients a certain degree of hypoferritinemia persist after the diagnosis, despite a good
      compliance and clinical response to gluten-free diet. These patients are usually
      premenopausal women in whom the cyclic menstrual bleeding and the oral iron intake are not
      balanced.

      The aim of the study is to compare the efficacy of a pharmacological therapy, frequently not
      tolerated, and a dietary approach through a iron-rich diet in this subset of patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ferritin levels (ng/mL) increase &gt; 95% compared to basal levels</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin levels (g/dL), compared to basal levels</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron levels (mcd/dl), compared to basal levels</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transferrin saturation (%, ratio of serum iron and total iron-binding capacity), compared to basal levels</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of participants with treatment-related adverse events assessed through NRS (number rating scales)</measure>
    <time_frame>12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Degree of compliance to therapy assessed through telephone interviews (number of pills taken)</measure>
    <time_frame>12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Degree of compliance to diet assessed through compliance questionnaires (mg of irons ingested)</measure>
    <time_frame>12 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Celiac Disease</condition>
  <condition>Iron Deficiency (Without Anemia)</condition>
  <arm_group>
    <arm_group_label>Iron sulfate 105 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Iron sulfate 105 mg: 1 pill/day is administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iron-rich diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron-rich diet recommendations are given</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron sulfate 105 mg</intervention_name>
    <description>Daily supplementation with iron sulfate 105 mg 1 pill/day</description>
    <arm_group_label>Iron sulfate 105 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron-rich diet</intervention_name>
    <arm_group_label>Iron-rich diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Celiac patients on gluten free diet since 1 year

          -  iron deficiency (ferritin &lt;15 ng/L or ferritin 15-20 + transferrin saturation &lt;15%)

        Exclusion Criteria:

          -  allergy to iron supplementation

          -  anemia

          -  pregnancy or breastfeeding

          -  menopause

          -  organic or psychiatric diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesca Francesca, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gastroenterology and Endoscopy Unit Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Department of Pathophysiology and Transplantation Università degli Studi di Milano - Italy.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesca Ferretti, MD</last_name>
    <phone>0039 0255033384</phone>
    <email>francesca.ferretti01@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Ferretti, MD</last_name>
      <phone>0039 0255033384</phone>
      <email>francesca.ferretti01@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Luca Elli, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federica Branchi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2016</study_first_submitted>
  <study_first_submitted_qc>October 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2016</study_first_posted>
  <last_update_submitted>March 11, 2017</last_update_submitted>
  <last_update_submitted_qc>March 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</investigator_affiliation>
    <investigator_full_name>Francesca Ferretti, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

